Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer

Journal of the American College of Surgeons

Volumn 210, Issue 5, 2010, Pages 767-776

  Johnson, Sara M ^a   Gulhati, Pat ^b,c,e   Rampy, Bill A ^a   Han, Yimei ^b   Rychahou, Piotr G ^c,e   Doan, Hung Q ^a,b   Weiss, Heidi L ^d,e   Evers, B Mark ^c,e  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN P85; S6 KINASE; BIOLOGICAL MARKER; PROTEIN SERINE THREONINE KINASE; RIBOSOMAL PROTEIN S6 KINASE, 70KD, POLYPEPTIDE 1; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; CANCER STAGING; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE CULTURE; TUMOR LOCALIZATION; CASE CONTROL STUDY; COHORT ANALYSIS; COLON TUMOR; ENZYMOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; RECTUM TUMOR;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; COLONIC NEOPLASMS; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECTAL NEOPLASMS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION;

EID: 77952311165     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2009.12.008     Document Type: Article

References (37)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 59 (2009) 225-249
2. Griffin M.R., Bergstralh E.J., Coffey R.J., et al. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 60 (1987) 2318-2324
3. Kobayashi M., Nagata S., Iwasaki T., et al. Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A 96 (1999) 4874-4879
4. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
5. Philp A.J., Campbell I.G., Leet C., et al. The phosphatidylinositol 3′-kinase p85α gene is an oncogene in human ovarian and colon tumors. Cancer Res 61 (2001) 7426-7429
6. Roy H.K., Olusola B.F., Clemens D.L., et al. AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis 23 (2002) 201-205
7. Shaw R.J., and Cantley L.C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441 (2006) 424-430
8. Brugge J., Hung M.C., and Mills G.B. A new mutational AKTivation in the PI3K pathway. Cancer Cell 12 (2007) 104-107
9. Rychahou P.G., Jackson L.N., Silva S.R., et al. Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma. Ann Surg 243 (2006) 833-842 discussion 843-834
10. Khaleghpour K., Li Y., Banville D., et al. Involvement of the PI 3-kinase signaling pathway in progression of colon adenocarcinoma. Carcinogenesis 25 (2004) 241-248
11. Itoh N., Semba S., Ito M., et al. Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer 94 (2002) 3127-3134
12. Rychahou P.G., Murillo C.A., and Evers B.M. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL). Surgery 138 (2005) 391-397
13. Rychahou P.G., Kang J., Gulhati P., et al. Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proc Natl Acad Sci U S A 105 (2008) 20315-20320
14. Sheng H., Shao J., Townsend Jr. C.M., and Evers B.M. Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells. Gut 52 (2003) 1472-1478
15. Wang Q., Li N., Wang X., et al. Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3′-kinase inhibition in the KM20 human colon cancer cell line. Clin Cancer Res 8 (2002) 1940-1947
16. Guertin D.A., and Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 12 (2007) 9-22
17. Chiang G.G., and Abraham R.T. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J Biol Chem 280 (2005) 25485-25490
18. Gulhati P., Cai Q., Li J., et al. Targeted inhibition of mTOR signaling inhibits tumorigenesis of colorectal cancer. Clin Cancer Res 15 (2009) 7207-7216
19. Iacopetta B. Are there two sides to colorectal cancer?. Int J Cancer 101 (2002) 403-408
20. Altomare D.A., Tanno S., De Rienzo A., et al. Frequent activation of AKT2 kinase in human pancreatic carcinomas. J Cell Biochem 87 (2002) 470-476
21. Yuan Z.Q., Sun M., Feldman R.I., et al. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene 19 (2000) 2324-2330
22. Han Z., Wu K., Shen H., et al. Akt1/protein kinase B alpha is involved in gastric cancer progression and cell proliferation. Dig Dis Sci 53 (2008) 1801-1810
23. Carpten J.D., Faber A.L., Horn C., et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448 (2007) 439-444
24. Bleeker F.E., Felicioni L., Buttitta F., et al. AKT1(E17K) in human solid tumours. Oncogene 27 (2008) 5648-5650
25. Wan X., Harkavy B., Shen N., et al. Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26 (2007) 1932-1940
26. Manning B.D. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol 167 (2004) 399-403
27. Carracedo A., Ma L., Teruya-Feldstein J., et al. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118 (2008) 3065-3074
28. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
29. Giovannucci E., and Ogino S. DNA methylation, field effects, and colorectal cancer. J Natl Cancer Inst 97 (2005) 1317-1319
30. Distler P., and Holt P.R. Are right- and left-sided colon neoplasms distinct tumors?. Dig Dis 15 (1997) 302-311
31. Bufill J.A. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 113 (1990) 779-788
32. Wistuba I.I., Behrens C., Albores-Saavedra J., et al. Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma. Clin Cancer Res 9 (2003) 3615-3619
33. Edkins S., O'Meara S., Parker A., et al. Recurrent KRAS codon 146 mutations in human colorectal cancer. Cancer Biol Ther 5 (2006) 928-932
34. Gupta S., Ramjaun A.R., Haiko P., et al. Binding of ras to phosphoinositide 3-kinase p110α is required for ras-driven tumorigenesis in mice. Cell 129 (2007) 957-968
35. Lim K.H., and Counter C.M. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance. Cancer Cell 8 (2005) 381-392
36. Junttila M.R., and Evan G.I. p53-a Jack of all trades but master of none. Nat Rev Cancer 9 (2009) 821-829
37. Feng Z., Zhang H., Levine A.J., and Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci U S A 102 (2005) 8204-8209